459 related articles for article (PubMed ID: 35461837)
1. CX3CL1 inhibits NLRP3 inflammasome-induced microglial pyroptosis and improves neuronal function in mice with experimentally-induced ischemic stroke.
Ge Y; Wang L; Wang C; Chen J; Dai M; Yao S; Lin Y
Life Sci; 2022 Jul; 300():120564. PubMed ID: 35461837
[TBL] [Abstract][Full Text] [Related]
2. Curcumin Ameliorates White Matter Injury after Ischemic Stroke by Inhibiting Microglia/Macrophage Pyroptosis through NF-
Ran Y; Su W; Gao F; Ding Z; Yang S; Ye L; Chen X; Tian G; Xi J; Liu Z
Oxid Med Cell Longev; 2021; 2021():1552127. PubMed ID: 34630845
[TBL] [Abstract][Full Text] [Related]
3. ChemR23 signaling ameliorates brain injury via inhibiting NLRP3 inflammasome-mediated neuronal pyroptosis in ischemic stroke.
Liu L; Zhang J; Lu K; Zhang Y; Xu X; Deng J; Zhang X; Zhang H; Zhao Y; Wang X
J Transl Med; 2024 Jan; 22(1):23. PubMed ID: 38178174
[TBL] [Abstract][Full Text] [Related]
4. Salvianolic Acids for Injection alleviates cerebral ischemia/reperfusion injury by switching M1/M2 phenotypes and inhibiting NLRP3 inflammasome/pyroptosis axis in microglia in vivo and in vitro.
Ma DC; Zhang NN; Zhang YN; Chen HS
J Ethnopharmacol; 2021 Apr; 270():113776. PubMed ID: 33421597
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury through NLRP3 Inflammasome-Mediated Pyroptosis Inhibition via Activating Nrf2.
Xiao L; Dai Z; Tang W; Liu C; Tang B
Oxid Med Cell Longev; 2021; 2021():9925561. PubMed ID: 35003524
[TBL] [Abstract][Full Text] [Related]
6. Lipocalin-2-mediated astrocyte pyroptosis promotes neuroinflammatory injury via NLRP3 inflammasome activation in cerebral ischemia/reperfusion injury.
Li J; Xu P; Hong Y; Xie Y; Peng M; Sun R; Guo H; Zhang X; Zhu W; Wang J; Liu X
J Neuroinflammation; 2023 Jun; 20(1):148. PubMed ID: 37353794
[TBL] [Abstract][Full Text] [Related]
7. Edaravone dexborneol provides neuroprotective benefits by suppressing NLRP3 inflammasome-induced microglial pyroptosis in experimental ischemic stroke.
Hu R; Liang J; Ding L; Zhang W; Liu X; Song B; Xu Y
Int Immunopharmacol; 2022 Dec; 113(Pt A):109315. PubMed ID: 36279668
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein receptor (LDLR) regulates NLRP3-mediated neuronal pyroptosis following cerebral ischemia/reperfusion injury.
Sun R; Peng M; Xu P; Huang F; Xie Y; Li J; Hong Y; Guo H; Liu Q; Zhu W
J Neuroinflammation; 2020 Nov; 17(1):330. PubMed ID: 33153475
[TBL] [Abstract][Full Text] [Related]
9. TRIM27 ameliorates ischemic stroke by regulating NLRP3 inflammasome-mediated pyroptosis via the Akt/Nrf2/HO-1 signaling.
Wei X; Zhang T; Ma C; Zhang M; Jin L; Ma X; Zhang Z
Exp Neurol; 2024 Jan; 371():114599. PubMed ID: 37914066
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment of Indobufen and Aspirin and their Combinations with Clopidogrel or Ticagrelor Alleviates Inflammasome Mediated Pyroptosis Via Inhibiting NF-κB/NLRP3 Pathway in Ischemic Stroke.
Li F; Xu D; Hou K; Gou X; Lv N; Fang W; Li Y
J Neuroimmune Pharmacol; 2021 Dec; 16(4):835-853. PubMed ID: 33512659
[TBL] [Abstract][Full Text] [Related]
11. Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation
Zhu H; Jian Z; Zhong Y; Ye Y; Zhang Y; Hu X; Pu B; Gu L; Xiong X
Front Immunol; 2021; 12():714943. PubMed ID: 34367186
[TBL] [Abstract][Full Text] [Related]
12. METTL14 regulates microglia/macrophage polarization and NLRP3 inflammasome activation after ischemic stroke by the KAT3B-STING axis.
Li Y; Li J; Yu Q; Ji L; Peng B
Neurobiol Dis; 2023 Sep; 185():106253. PubMed ID: 37541353
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow mesenchymal stem cell-derived exosomes attenuate cerebral ischemia-reperfusion injury-induced neuroinflammation and pyroptosis by modulating microglia M1/M2 phenotypes.
Liu X; Zhang M; Liu H; Zhu R; He H; Zhou Y; Zhang Y; Li C; Liang D; Zeng Q; Huang G
Exp Neurol; 2021 Jul; 341():113700. PubMed ID: 33741350
[TBL] [Abstract][Full Text] [Related]
14. MiR-139 protects against oxygen-glucose deprivation/reoxygenation (OGD/R)-induced nerve injury through targeting c-Jun to inhibit NLRP3 inflammasome activation.
Wang QS; Luo XY; Fu H; Luo Q; Wang MQ; Zou DY
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105037. PubMed ID: 32807449
[TBL] [Abstract][Full Text] [Related]
15. Intermittent theta-burst stimulation improves motor function by inhibiting neuronal pyroptosis and regulating microglial polarization via TLR4/NFκB/NLRP3 signaling pathway in cerebral ischemic mice.
Luo L; Liu M; Fan Y; Zhang J; Liu L; Li Y; Zhang Q; Xie H; Jiang C; Wu J; Xiao X; Wu Y
J Neuroinflammation; 2022 Jun; 19(1):141. PubMed ID: 35690810
[TBL] [Abstract][Full Text] [Related]
16. TMEM59 protects against cerebral ischemic stroke by suppressing pyroptosis and microglial activation.
Zhang L; Wang T; Chen XF; Xu ZX; Cao JB; Sun H
Biochem Biophys Res Commun; 2021 Mar; 543():72-79. PubMed ID: 33517129
[TBL] [Abstract][Full Text] [Related]
17. PHLDA1 Blockade Alleviates Cerebral Ischemia/Reperfusion Injury by Affecting Microglial M1/M2 Polarization and NLRP3 Inflammasome Activation.
Zhao H; Liu Y; Chen N; Yu H; Liu S; Qian M; Zhang Z
Neuroscience; 2022 Apr; 487():66-77. PubMed ID: 35093445
[TBL] [Abstract][Full Text] [Related]
18. Procyanidins exhibits neuroprotective activities against cerebral ischemia reperfusion injury by inhibiting TLR4-NLRP3 inflammasome signal pathway.
Yang B; Sun Y; Lv C; Zhang W; Chen Y
Psychopharmacology (Berl); 2020 Nov; 237(11):3283-3293. PubMed ID: 32729095
[TBL] [Abstract][Full Text] [Related]
19. JLX001 ameliorates cerebral ischemia injury by modulating microglial polarization and compromising NLRP3 inflammasome activation via the NF-κB signaling pathway.
Bian HJ; Xu SY; Li HQ; Jia JQ; Ye L; Shu S; Xia SN; Gu Y; Zhu X; Xu Y; Cao X
Int Immunopharmacol; 2021 Dec; 101(Pt A):108325. PubMed ID: 34740080
[TBL] [Abstract][Full Text] [Related]
20. Hirudin alleviates acute ischemic stroke by inhibiting NLRP3 inflammasome-mediated neuroinflammation: In vivo and in vitro approaches.
Li WQ; Qin ZS; Chen S; Cheng D; Yang SC; Choi YMM; Chu B; Zhou WH; Zhang ZJ
Int Immunopharmacol; 2022 Sep; 110():108967. PubMed ID: 35724604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
